Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On November 17, 2023, UBS cut its rating of Cano Health to “Sell”, citing the Company’s deteriorating liquidity position. UBS opined that “elevated third-party medical expenses will have a sustained negative effect on the company’s already challenged liquidity position.”
On this news, Cano’s stock price fell 6.72%, to close at $7.63 per share on November 17, 2023.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| WOLF | Wolfspeed, Inc. | January 17, 2025 | Join |
| SUI | Sun Communities, Inc. | February 10, 2025 | Join |
| SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |